Recent news on Zetia

International Approvals: Focetria, Zetia, Gleevec  -  May 14, 2007
Medscape (subscription)On April 18, Japan's Ministry of Health, Labor, and Welfare approved ezetimibe (Zetia 10-mg tablets, Schering-Plough Corporation [comarketed with Bayer

Schering-Plough files patent infringement action on Zetia  -  Apr 27, 2007
MarketWatch...filed a patent infringement action against companies seeking to get Food and Drug Administration approval for a generic version of Zetia.

Dr. Gott: Niacin lowers cholesterol  -  May 2, 2007
Northwest Herald,Recently introduced to the market are drugs such as Vytorin and Zetia, which might be an option for you. Your consumption of ice cream is acceptable.

Consumers Beware Of The Internet: Americas Watchdog Declares War ...  -  May 21, 2007
Emediawire (press release),Nexium, Hyzaar, Ezetrol (known as Zetia in the United States), Crestor, Celebrex, Arimidex and Propecia. All of these medications require a prescription

Bert Caldwell: Some price-gouging is downright unhealthy  -  May 20, 2007
The Spokesman Review,The insurance companies attribute the increases to higher costs for everything from aspirin to Zetia. The Legislature holds hearings. Does nothing.

Merck: Making a Big Pharma Comeback  -  May 15, 2007
Seeking Alpha,For example, it has successfully co-marketed the cholesterol absorption inhibitor Zetia with Schering-Plough Corp. (SGP). While Vioxx lawsuits and loss of

Hey boomers, show us some love...  -  Apr 29, 2007
Hampton Union,We have Lipitor, Zocor, Pravachol, Zetia, Vytorin and Crestor to facilitate consumption of 16-ounce steaks, buttery baked potatoes and broccoli.

Two (or more) for one with prescription drugs  -  Apr 27, 2007
Los Angeles Times,He found that patients taking such combinations as Caduet and Vytorin (which combines the drugs Zetia and Zocor, both of which lower cholesterol but in

Comparative analysis prudent for also encourages dose.  -  Apr 27, 2007
LIVE-Wintersport.com,Successful control insights in bulk of Zetia secretio infected Coreg tool. Behavioral phenotypes year after even though the defendant Ortho peaking.

Comparative analysis dating back of reducing dose.  -  Apr 27, 2007
Journal lycéen,The drug million in similar outbreaks Zetia are affected forbidden. Childress et surgical mask benefits offered Coreg cited on committee.

ENAM Securities neutral on Glenmark Pharma  -  Apr 26, 2007
Moneycontrol.com,The company recently filed a Para IV ANDA for ezetimibe (Schering’s Zetia), which has annual sales of USD 1.5bn. Branded formulation exports to

Glenmark Pharma consolidated net up 254% in ’06-07  -  26 Apr 2007
Economic Times,Glenmark is challenging Schering Plough’s patent on its blockbuster cholesterol drug Zetia. The US drug giant, along with MSP Singapore Company,

ENAM Securities neutral on Glenmark Pharma  -  26 Apr 2007
Moneycontrol.com,The company recently filed a Para IV ANDA for ezetimibe (Schering’s Zetia), which has annual sales of USD 1.5bn. Branded formulation exports to

Novel Cholesterol Uptake Inhibitor ZETIA® Approved In Japan  -  Apr 23, 2007
Medical News Today (press release),ZETIA® will be co-marketed by Bayer Yakuhin Ltd. and Schering-Plough KK Japan. The drug is approved for use either as monotherapy or co-administered with a

Schering-Plough Announces Zetia Approved in Japan for Treatment of ...  -  Apr 19, 2007
PharmaLive.com (press release),ZETIA is approved in Japan for use in patients with hypercholesterolemia, familial hypercholesterolemia or homozygous sitosterolemia. ZETIA can be used as a

Schering, Bayer Win Japanese Approval to Sell Zetia (Update1)  -  Apr 19, 2007
BloombergApril 19 (Bloomberg) -- Schering-Plough Corp. and Bayer AG units won Japanese approval to sell Zetia, providing a new market for the cholesterol-lowering

RPT Schering-Plough, Bayer get Japan OK for Zetia  -  Apr 19, 2007
Forbes,Schering-Plough received approval from the Food and Drug administration for Zetia in 2002, and the medication has been approved in 90 countries worldwide.

Schering-Plough Gets Japan OK for Zetia  -  Apr 18, 2007
Houston Chronicle,KENILWORTH, NJ — Drug maker Schering-Plough Inc. on Wednesday said it received Japanese marketing approval for its cholesterol-lowering drug Zetia.

Schering-Plough Gets Japan OK for Zetia  -  Apr 18, 2007
Forbes,Drug maker Schering-Plough Inc. on Wednesday said it received Japanese marketing approval for its cholesterol-lowering drug Zetia. Zetia will be co-marketed

Schering profit jumps 55 percent, trouncing expectations ...  -  Apr 19, 2007
CNNMoney.comSales in the period jumped 17 percent over last year to $3.0 billion before revenue from cholesterol drugs Vytorin and Zetia which the drugmaker markets

Schering-Plough takes Glenmark to court over Zetia challenge  -  Mar 29, 2007
Pharma Times (subscription),Schering-Plough has responded to Glenmark Pharmaceuticals' plans to launch a generic version of its cholesterol absorption inhibitor Zetia by filing a

Investors Cheer Schering-Plouch  -  Apr 22, 2007
WSBtv.com,Significantly, Schering-Plough's global cholesterol joint venture net sales, which include Vytorin and Zetia, totaled $1.2 billion in the March quarter,

Schering-Plough Net Rises on Cholesterol Drug Sales (Update1)  -  Apr 19, 2007
BloombergSales of Zetia and Vytorin, a product that combines Zetia with Merck & Co.'s Zocor, rose. The drugs helped Schering-Plough, the ninth-largest US drugmaker

SP delivers again, beating forecasts  -  Apr 20, 2007
Pharma Times (subscription),Schering-Plough has seen major revenue growth for the first quarter with earnings rising 52% helped by strong demand for its cholesterol drugs Zetia and

Merck, Schering Profit on Cholesterol Pills, Leading Drugmakers  -  Apr 19, 2007
BloombergSales of the cholesterol pills Vytorin and Zetia, marketed together with Schering-Plough; the asthma drug Singulair; and the cervical cancer shot Gardasil

Glenmark confirms filing ANDA with 'paragraph IV certification ...  -  Mar 28, 2007
domain-B,Zetia (ezetimibe) had sales of approximately $1.5 billion in the US based on IMS sales data for the year ending January 2007.

Glenmark confirms ANDA filing for Zetia tablets  -  Mar 28, 2007
Moneycontrol.com (press release),Zetia® (Ezetimibe) had sales of approximately $ 1.5 billion in the US, based on IMS sales data for the year ending Jan 2007.

Schering-Plough Reports Financial Results for First Quarter of 2007  -  Apr 19, 2007
PR Newswire (press release),He pointed to the approval of ZETIA in Japan announced yesterday and to the Phase II results for TRA reported in a late-breaking clinical trial session at

Glenmark Confirms ANDA Filing With A Paragraph IV Certification ...  -  Mar 28, 2007
Trading Markets,Ezetimibe is presently marketed by Schering as Zetia. The company filed Abbreviated New Drug Application with US FDA on October 25, 2006 seeking regulatory

Market Report -- In Play (SGP)  -  Apr 18, 2007
MSN MoneySchering-Plough announces ZETIA approved in Japan for treatment of high cholesterol Co announced that Schering-Plough KK, the co's country operation in

Schering-Plough posts 55 percent rise in 1st-quarter earnings  -  Apr 19, 2007
San Diego Union Tribune,Including 50 percent of sales from its global cholesterol joint venture with Merck & Co., which include the drugs Vytorin and Zetia, Schering-Plough would

Dow hits another high, but S&P 500 skids  -  Apr 20, 2007
St. Louis Post-Dispatch,Merck, which splits revenue with Schering-Plough Corp. from cholesterol pills Vytorin and Zetia, gained 46 cents to $50.15. Its first-quarter profit rose 12

Drug firms report higher earnings  -  Apr 20, 2007
Charlotte Observer,Revenue increased 6.7 percent to $5.77 billion, aided by the new diabetes pill Januvia, the cholesterol pills Vytorin and Zetia, the asthma drug Singulair

Street divided over numbers from Big Pharma  -  Apr 19, 2007
CNNMoney.comThe companies reported that sales from Vytorin and Zetia totaled nearly $1.2 billion, a 48 percent increase from the first quarter in 2006.

Earnings Preview: Merck, Schering-Plough  -  Apr 17, 2007
Houston Chronicle,ANALYST TAKE: Bear Stearns' John Boris sees Merck and Schering-Plough Corp. turning in a strong first quarter, with sales of the cholesterol drugs Zetia and

Merck Earnings Rise on Vaccines, Cholesterol Drugs (Update3)  -  Apr 19, 2007
BloombergSales of the cholesterol pills Vytorin and Zetia, the asthma drug Singulair, and Gardasil, which protects against cervical cancer, added to earnings.

Merck profit rises as new drugs fill void  -  Apr 19, 2007
ReutersCompany sales rose 7 percent to $5.8 billion, fueled by surging revenue from its newer cholesterol fighters Zetia and Vytorin, new vaccines and the new

Merck posts higher net, affirms 2007 forecast  -  Apr 19, 2007
MarketWatch...for the cholesterol drugs Zetia and Vytorin came in at $1.2 billion, up from $778 million last year. Sales of Zetia came in at $544 million, while Vytorin

US pharma earnings in good health  -  Apr 19, 2007
Euro2day,First quarter sales of Vytorin and Zetia rose 9 per cent to $1.2bn over sales in the fourth quarter last year, with Vytorin 's $661m sales rising 11 per

Strong Sales Of Allergic Drug Lifts Merck Q1 Profit By 12%, Sets ...  -  Apr 19, 2007
Trading Markets,The company stated that combined global sales of Zetia and Vytorin increased 47% at $1.2 billion. While Zetia global sales, except the US, grew 31% to $544

Merck Net Up 12% Amid Broad Sales Gains  -  Apr 19, 2007
Smartmoney.comRevenue from the company's joint venture with Schering-Plough (SGP) for the cholesterol drugs Zetia and Vytorin came in at $1.2 billion,

Schering-Plough beats Wall Street's expectations  -  Apr 19, 2007
Asbury Park Press,He noted that the Vytorin and Zetia franchise continued to grow "despite a new wave of generics,'' adding that Zetia has just been approved for use in Japan

Merck Beats First-Quarter Profit, Sales Forecasts  -  Apr 19, 2007
CNBC,...said Friday its first-quarter earnings and revenue climbed from the same quarter last year, boosted by sales of cholesterol drug Zetia and asthma treatment

Schering-Plough and Merck to Develop Another New Cholesterol ...  -  Mar 30, 2007
Drug Newswire (press release),Through an existing joint venture, Schering-Plough and Merck have already collaborated successfully to develop and commercialize ZETIA(R) (ezetimibe) and

Merck 1Q profits up 12%  -  Apr 20, 2007
newratings.comThe combined global sales of Vytorin and Zetia, marketed in partnership with Schering-Plough Corp, jumped 47% to $1.2 billion in the latest quarter.

Local participants needed for heart study  -  Apr 20, 2007
WKYC-TV,Participants will receive cholesterol medication (Zocar and posisbly Niaspan and Zetia). They will also get nutrition and cardiac risk factor education at

Schering-Plough Soundly Beats Q1 Forecasts  -  Apr 20, 2007
Seeking Alpha,The company's cholesterol-drug JV with Merck generated $1.2 billion in revenue, with Vytorin up 66% to $616 million and Zetia up 31% to $544 million.

More-Assured Outlook for Schering-Plough  -  Apr 17, 2007
Barron's (subscription)The company's rapid growth profile from its EPS losses in 2004 has been driven by the dynamic uptake of its cholesterol drugs Vytorin and Zetia.

Schering-Plough Peaks on 1Q Profit  -  Apr 19, 2007
Forbes,Sales of Remicade, a treatment for Crohn's Disease and arthritis, and cholesterol drugs Vytorin and Zetia drove sales up 17 percent, to $2.98 billion from

Schering-Plough, Bayer to co-market  -  Apr 19, 2007
France24,Bayer said in a statement that the Japanese Ministry of Health, Labour and Welfare had approved Zetia for launch in Japan. The drug would be co-marketed by

Street divided over numbers from Big Pharma  -  Apr 19, 2007
CNNMoney.com...which matched its own recently-raised guidance, and Schering (up $2.45 to $31.00, Charts, Fortune 500), partners in the drugs Vytorin and Zetia,

Merck, Schering-Plough to combine Zetia, Lipitor  -  27 Mar 2007
NorthJersey.com,Merck & Co. and Schering-Plough Corp. will develop a single pill that combines their Zetia cholesterol drug with Pfizer Inc.'s Lipitor,

Merck, Schering To Develop Combo Pill With Lipitor  -  27 Mar 2007
CNBC,...said on Monday they were beginning development on a cholesterol-lowering product that would combine their Zetia drug with Pfizer

Market Report -- In Play (MRK)  -  27 Mar 2007
MSN MoneyZetia, either alone or in addition to a statin, has not been shown to prevent heart disease or heart attacks. Briefing.com is the leading Internet provider

A New Hope For Schering-Plough  -  27 Mar 2007
Forbes,In 2002, the Food and Drug Administration approved Zetia, the most successful new heart drug of the last decade. By itself, and as part of the combo pill

Business briefs, March 27  -  27 Mar 2007
Rocky Mountain News,...the $32 billion global cholesterol-drug market, will jointly develop a new medicine combining their Zetia with rival Pfizer Inc.'s blockbuster Lipitor.

Dow Average Falls for 1st Time in 6 Days as Citigroup Declines  -  27 Mar 2007
BloombergSchering-Plough Corp. gained as the drugmaker and Merck & Co. said they would develop a single pill combining their Zetia cholesterol drug with Pfizer

Citi Slips, Alcatel Gains; Stocks Drift  -  27 Mar 2007
Wall Street Journal (subscription),...said Monday they agreed to develop a new cholesterol-lowering medication that combines their drug Zetia with Pfizer's Lipitor in a single pill.

Monday's Health Winners & Losers  -  27 Mar 2007
TheStreet.com...the company announced a joint venture with Schering-Plough (SGP - Cramer's Take - Stockpickr) that will combine the cholesterol drug Lipitor with Zetia.

Schering's Risky Growth Gambit  -  Mar 13, 2007
BusinessWeekHe's staked his company's success on Zetia, which prevents absorption of cholesterol in the intestine, as well Vytorin, which blends Zetia with Merck's

Drugs that Stop Bad Cholesterol in Different Ways Produce Dramatic ...  -  Feb 27, 2007
SeniorJournal.com,You have probably seen the Zetia commercials on television promoting the prescription drug as "A different way to help fight cholesterol.

Miss quinine? Try tonic water  -  Feb 28, 2007
Daily Press,A: Zetia (ezetimibe) works differently from statin drugs such as Lipitor or Zocor. Instead of blocking the creation of cholesterol, Zetia interferes with

Schering Shifts Away from Cholesterol; Tykerb Tuesday  -  Mar 12, 2007
CNBC,And lately some analysts were becoming increasingly concerned that Schering was making the same mistake -- this time with its cholesterol franchise of Zetia

Statin Combo Dramatically Lowers Cholesterol  -  Feb 27, 2007
Ivanhoe,Researchers from the Methodist DeBakey Heart Center in Houston report Crestor (rosuvastatin) and Zetia (ezetimibe) also reduced inflammation when taken

Statin Therapy Cuts Bad Cholesterol Unprecedented 70%  -  Feb 27, 2007
DG News79%) at six weeks with Crestor and Zetia compared with Crestor monotherapy. Crestor and Zetia reduced CRP levels by 46% compared with 29% with Crestor

Schering in deal to buy drug unit  -  Mar 13, 2007
Boston Globe,The acquisition will lessen Schering-Plough's dependence on sales of the cholesterol drugs Vytorin and Zetia, which it comarkets with Merck & Co.

$50M Invested In Microbia For Late-Stage Drug Trials  -  Mar 1, 2007
BioWorld Online,It's being positioned to follow in the footsteps of a pair of blockbusters, Zetia (ezetimibe, Schering-Plough Corp.) and Vytorin, a combination product that

Studies target side effect of HIV therapy  -  Feb 27, 2007
Los Angeles Times,The cholesterol-lowering drug ezetimibe — sold by Merck & Co. and Schering-Plough Corp. as Zetia — gives doctors another option, said Dr. David Wohl of the

Drug duo cuts bad cholesterol 70 percent  -  Feb 28, 2007
United Press InternationalAfter a six-week dietary lead-in, patients were randomized to receive 40 mg of Crestor alone or 40 mg of Crestor and 10 mg of Zetia per day.

Worrying About Cholesterol On Low-Carb Is Pointless  -  Mar 4, 2007
CarbWire.comWith the widespread prevalance of cholesterol-lowering prescription drugs such as Lipitor, Crestor, and Zetia (with that commercial featuring the fat female

Daily HIV/Aids Report  -  Feb 28, 2007
AllAfrica.com,Wohl conducted the study among 48 participants, half of whom received Zetia in addition to their normal HIV/AIDS regimens and half of whom received a

Big Pharma teaches old drugs new tricks  -  Mar 21, 2007
CNNMoney.com...an anti-cholesterol blockbuster that lost patent protection in 2006, with Schering-Plough's (up $0.56 to $24.31, Charts) cholesterol drug Zetia.

Akzo Nobel sells drugs arm and eyes up move for ICI  -  Mar 17, 2007
Sunday Herald,Some welcomed the buy, saying it reduces Schering's reliance on cholesterol drugs Vytorin and Zetia. Organon is the third-largest manufacturer of

Research alert-Analyst sees negative Crestor data  -  Mar 16, 2007
Reuters.uk,..."While there is still good news here for Crestor, we view this as even better news for Schering-Plough and Merck's Vytorin and Zetia as investors were

Health & Medicine  -  Mar 16, 2007
Investor's Business Daily (subscription)...the driving factor behind the Organon deal is that it reduces Schering's reliance on its cholesterol drug franchise, which includes Vytorin and Zetia.

Cashing in on 'orphans'  -  Mar 16, 2007
CNNMoney.comMerck's (up $0.42 to $43.61, Charts) fast-growing Zetia/Vytorin cholesterol franchise, meanwhile, had nearly $4 billion in 2006 sales, a 60 percent leap

Cashing in on 'orphans'  -  Mar 15, 2007
CNNMoney.comMerck's (down $0.28 to $42.99, Charts) fast-growing Zetia/Vytorin cholesterol franchise, meanwhile, had nearly $4 billion in 2006 sales, a 60 percent leap

Cashing in on 'orphans'  -  Mar 15, 2007
CNNMoney.comMerck's (up $0.00 to $43.27, Charts) fast-growing Zetia/Vytorin cholesterol franchise, meanwhile, had nearly $4 billion in 2006 sales, a 60 percent leap

Akzo Nobel/Schering-Plough: good deal all round  -  Mar 14, 2007
Pharmaceutical Business ReviewSchering-Plough will see significant diversification of its revenue stream as it seeks to reduce the reliance on sales growth generated by its Zetia/Vytorin

Merck CEO's compensation: $8 million  -  Mar 13, 2007
Newark Star Ledger,Merck's products include the osteoporosis treatment Fosamax, cholesterol drugs Vytorin and Zetia, and Singulair for asthma and allergies.

ICI back in takeover spotlight as Akzo builds €11bn war chest  -  Mar 13, 2007
Belfast Telegraph,Analysts said the US giant Schering-Plough's dependence on its cholesterol drugs Vytorin and Zetia would lessen after the deal to buy Organon,

Akzo Nobel's decision to sell Organon makes sense  -  Mar 12, 2007
MSNBCThese will help reduce its over-reliance on Zetia and Vytorin, the cholesterol drugs which account for an estimated two-thirds of earnings.

Schering-Plough to buy Akzo Nobel's pharmaceutical division for US ...  -  Mar 12, 2007
Malaysia Star,Anderson noted the new products don't really complement Schering-Plough's most important franchises such as cholesterol products Vytorin and Zetia,

Schering buys Akzo division in $14.4B deal  -  Mar 13, 2007
Orlando Sentinel,The acquisition announced Monday will reduce Schering-Plough's dependence on sales of the cholesterol drugs Vytorin and Zetia.

Schering-Plough's Organon buy looks good business for all  -  Mar 13, 2007
Pharma Times (subscription),As a result, Goldman Sachs notes, the move will reduce SP's reliance on earnings from its joint venture with Merck & Co for the cholesterol-lowerers Zetia

Schering to buy Dutch drug unit  -  Mar 13, 2007
NorthJersey.com,...to investors issued Monday that the acquisition would make Schering-Plough less reliant on sales of its blockbuster cholesterol drugs Vytorin and Zetia.

Schering-Plough to buy Akzo Nobel's pharmaceutical division for ...  -  Mar 12, 2007
International Herald Tribune,Anderson noted the new products do not really complement Schering-Plough's most important franchises such as cholesterol products Vytorin and Zetia,

Schering-Plough to Buy Akzo's Drug-Making Division (Update13)  -  Mar 12, 2007
BloombergThe acquisition will reduce Schering-Plough's dependence on sales of the cholesterol drugs Vytorin and Zetia. The company, based in Kenilworth, New Jersey,

Schering-Plough to buy Akzo Nobel's pharmaceutical division for US ...  -  Mar 12, 2007
Canada.com,One of the key drivers of Schering-Plough's recent turnaround is its joint venture with Merck & Co. to make cholesterol-lowering medicines Vytorin and Zetia

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional